Medicxi Outlines Growth Ambitions For MG1 Fund
Executive Summary
Medicxi has made two investments to date from the $300M growth fund MG1 which it announced in 2017. Speaking at BIO-Europe Spring in Amsterdam, Medicxi Principal Giovanni Mariggi explained to Scrip how the fund selects assets to back.